Senior Director, Medical Affairs- Insights & Analytics
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Director, Medical Affairs Insights & Analytics to build the analytics center of excellence and leading a team. In this role, you will turn diverse data, including real-world, clinical, scientific engagement, and medical information, into actionable medical strategy. Collaborate with senior leaders across Medical, HEOR, RWE, Commercial analytics, Finance, and technology.
Job description
When & where
- Location: Sleepy Hollow, NY
- Work model: 4 days/week, on-site
- Travel percentage: Approximately 15%
Discover your role
- Establish and oversee the Medical Affairs analytics center of excellence, setting direction on methodologies, standards, and capabilities.
- Drive advanced, predictive, and AI/ML analytics solutions generating impactful insights to support planning, prioritization, and resource optimization
- Own executive dashboards, Key Performance Indicators and performance frameworks that measure and communicate the impact including medical care gaps
- Deliver valuable insights and reporting to Medical Affairs to inform strategy, operations, and the integrated planning cycle
- Partner with cross-functional collaborators enabling data-driven decision making and advising on the appropriate use of data assets and platforms
- Safeguard the integrity, governance, privacy compliance, and scalability of data and analytics ecosystems while championing digital transformation
- Build, coach, and mentor a high-performing analytics team, fostering a culture of data-driven decision making and continuous improvement
This role requires
- Advanced degree (MS, MBA, PharmD, PhD, MD, MPH, or equivalent) in data science, biostatistics, analytics, life sciences, pharmacy, medicine, public health, or a related field
- 12+ years of experience in healthcare, pharmaceutical, or life-sciences analytics, insights, or business intelligence, including 6+ years leading teams with complex cross-functional or matrixed initiatives
- Proven record of translating complex analyses into actionable insights and compelling, data-driven narratives, executive storytelling, and stakeholder-management skills
- Demonstrated expertise in advanced analytics, RWE, and healthcare data, plus KPI and performance framework design
- Strong understanding of Medical Affairs functions; Experience in Field Medical or as a Medical Science Liaison is preferred.
- Knowledge of data governance, privacy regulations, and compliance in healthcare analytics
- Hands-on experience with AI/ML applications and visualization tools
Requirements
- Advanced degree (MS, MBA, PharmD, PhD, MD, MPH, or equivalent) in data science, biostatistics, analytics, life sciences, pharmacy, medicine, public health, or a related field
- 12+ years of experience in healthcare, pharmaceutical, or life-sciences analytics, insights, or business intelligence
- 6+ years leading teams with complex cross-functional or matrixed initiatives
- Proven record of translating complex analyses into actionable insights and compelling, data-driven narratives, executive storytelling, and stakeholder-management skills
- Demonstrated expertise in advanced analytics, RWE, and healthcare data, plus KPI and performance framework design
- Strong understanding of Medical Affairs functions
- Experience in Field Medical or as a Medical Science Liaison is preferred
- Knowledge of data governance, privacy regulations, and compliance in healthcare analytics
- Hands-on experience with AI/ML applications and visualization tools
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.